Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine hesitancy among people with multiple sclerosis
Siew Mei Yap, Mahmood Al Hinai, Maria Gaughan, et al.
Multiple Sclerosis and Related Disorders (2021) Vol. 56, pp. 103236-103236
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Vaccination coverage and its determinants in patients with multiple sclerosis—a multicenter cross-sectional study
Paula Schade, Hai-Anh Nguyen, Julia Steinle, et al.
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access
Vaccination in multiple sclerosis: Tackling challenges and paving the way for effective immunization
René Carvajal, Carmen Tur, Blanca Borrás-Bermejo, et al.
Multiple Sclerosis Journal (2025)
Closed Access
COVID‐19 vaccination hesitancy among people with chronic neurological disorders: A position paper
Martin Rakuša, Şerefnur Öztürk, Elena Moro, et al.
European Journal of Neurology (2022) Vol. 29, Iss. 8, pp. 2163-2172
Open Access | Times Cited: 22
COVID-19 vaccines and patients with multiple sclerosis: willingness, unwillingness and hesitancy: a systematic review and meta-analysis
Amid Yazdani, Omid Mirmosayyeb, Elham Moases Ghaffary, et al.
Neurological Sciences (2022) Vol. 43, Iss. 7, pp. 4085-4094
Open Access | Times Cited: 19
Multiple sclerosis in the era of COVID-19: disease course, DMTs and SARS-CoV2 vaccinations
Maura Pugliatti, Thomas Berger, Hans‐Peter Hartung, et al.
Current Opinion in Neurology (2022) Vol. 35, Iss. 3, pp. 319-327
Closed Access | Times Cited: 18
Immunogenicity of a seasonal influenza and a pneumococcal polysaccharide vaccine in multiple sclerosis patients under disease modifying therapies: A single-center prospective study
Theodoros Marantos, Evdoxia Kyriazopoulou, Emmanouil Angelakis, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126001-126001
Closed Access | Times Cited: 2
Risk of Relapse After COVID-19 Vaccination Among Patients With Multiple Sclerosis in France
Xavier Moisset, Emmanuelle Leray, Chouki Chenaf, et al.
Neurology (2024) Vol. 103, Iss. 5
Closed Access | Times Cited: 2
COVID-19 and multiple sclerosis: challenges and lessons for patient care
Luca Prosperini, Georgina Arrambide, Elisabeth Gulowsen Celius, et al.
The Lancet Regional Health - Europe (2024) Vol. 44, pp. 100979-100979
Open Access | Times Cited: 2
COVID-19 vaccine hesitancy in Iranian patients with multiple sclerosis
Naghmeh Abbasi Kasbi, Fereshteh Ghadiri, Abdorreza Naser Moghadasi, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 60, pp. 103723-103723
Open Access | Times Cited: 13
Safety, immunogenicity, efficacy, and acceptability of COVID-19 vaccination in people with multiple sclerosis
Fioravante Capone, Mariagrazia Rossi, Alessandro Cruciani, et al.
Neural Regeneration Research (2022) Vol. Publish Ahead of Print
Open Access | Times Cited: 11
COVID-19 Vaccine Status, Intent, Hesitancy, and Disease-Related Beliefs in People with Multiple Sclerosis
Lisa Grech, Alastair Kwok, Mike Nguyen, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 410-410
Open Access | Times Cited: 5
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in
Maura Pugliatti, Hans‐Peter Hartung, Celia Oreja‐Guevara, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Era of COVID-19 in Multiple Sclerosis Care
Jonathan D. Krett, Amber Salter, Scott D. Newsome
Neurologic Clinics (2023) Vol. 42, Iss. 1, pp. 319-340
Open Access | Times Cited: 3
COVID‐19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in Denmark
Dominika Šťastná, Frederik Elberling, Luigi Pontieri, et al.
European Journal of Neurology (2023) Vol. 31, Iss. 3
Open Access | Times Cited: 3
Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: A systematic review and meta-analysis
Fan Ning, Xiang-qi Cao, Qingqing Wang, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23944-e23944
Open Access | Times Cited: 3
Implementing education: Personal communication with a healthcare professional is a critical step to address vaccine hesitancy for people with multiple sclerosis
Maya G. Panisset, Trevor J. Kilpatrick, L.E. Cofré Lizama, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 63, pp. 103933-103933
Open Access | Times Cited: 5
Vaccine hesitancy in people with multiple sclerosis
Jeannette Lechner‐Scott, Joshua S. Davis, Christopher H. Hawkes, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 65, pp. 104102-104102
Open Access | Times Cited: 5
Vaccine response in people with multiple sclerosis treated with fumarates
Matthew Tremblay, Sandra Vukusic, Mathura Shanmugasundaram, et al.
Multiple Sclerosis Journal - Experimental Translational and Clinical (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 2
COVID‐19 vaccine hesitancy in renal transplant recipients
Nikolina Bašić‐Jukić, Vesna Furić-Čunko, Bojan Jelaković
Therapeutic Apheresis and Dialysis (2021) Vol. 26, Iss. 2, pp. 482-483
Open Access | Times Cited: 6
COVID-19 vaccine hesitancy among Italian people with multiple sclerosis
Francesca Proietti, Doriana Landi, Marta Ponzano, et al.
Neurological Sciences (2022) Vol. 44, Iss. 3, pp. 803-808
Open Access | Times Cited: 4
Vaccination frequency in people newly diagnosed with multiple sclerosis
Sonia Darvishi, Ewan Donnachie, Christiane Gasperi, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 14, pp. 1831-1840
Open Access | Times Cited: 2
Emerging trends and challenges in multiple sclerosis in Europe: rethinking classification and addressing COVID-19 impact
Catharina Korsukewitz, Heinz Wiendl
The Lancet Regional Health - Europe (2024) Vol. 44, pp. 101017-101017
Open Access
Exploring the Barriers and Facilitators to Vaccination among the Immunocompromised Population: A Scoping Review
Anne Ejiegbu, Melody Shayanfar, Mario Brondani
(2024)
Closed Access
Vaccinations in patients with multiple sclerosis: a real-world, single-center experience
Elvira Sbragia, Dario Olobardi, Giovanni Novi, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 3
The Risk of Multiple Sclerosis Relapse After Vaccination
Hesham Abboud, Mauricio Farez
Neurology (2024) Vol. 103, Iss. 5
Closed Access
Page 1 - Next Page

Scroll to top